Susquehanna International Group’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-212,659
Closed -$500K 13863
2025
Q4
$500K Buy
+212,659
New +$409K ﹤0.01% 8786
2019
Q1
Sell
-1
Closed -$22K 9567
2018
Q4
$22K Buy
+1
New +$57.4K ﹤0.01% 8665
2018
Q1
Hold
0
9939
2017
Q4
Hold
0
8971
2017
Q3
Hold
0
8645
2017
Q2
Sell
-1
Closed -$439K 9642
2017
Q1
$470K Buy
+1
New +$381K ﹤0.01% 6584
2016
Q4
Hold
0
-$6K 9978
2016
Q3
Hold
0
8301
2016
Q2
Hold
0
8448
2016
Q1
Hold
0
8521
2015
Q4
Hold
0
8857
2015
Q3
Sell
-1
Closed -$1.84M 8235
2015
Q2
$1.72M Buy
+1
New +$2.18M ﹤0.01% 5038
2015
Q1
Hold
0
7206
2014
Q4
Hold
0
6637
2014
Q3
Hold
0
7550
2014
Q2
Hold
0
6723
2014
Q1
Hold
0
4554
2013
Q4
Hold
0
-$29K 9208
2013
Q3
Hold
0
8294

Other funds holding PALI

Susquehanna International Group's PALI Position: Q1 2026 in Review

Susquehanna International Group sold out of Palisade Bio (PALI) in Q1 2026, closing a stake of 212,659 shares — an estimated $500K sold.

Susquehanna International Group first reported a position in PALI in Q2 2015 and held it in 4 quarters. The position peaked at $1.72M in Q2 2015. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Susquehanna International Group reported no remaining Palisade Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 212,659 Palisade Bio shares in Q1 2026, an estimated $500K.
  • Susquehanna International Group first reported a position in Palisade Bio in Q2 2015 and held it in 4 quarters.
  • Susquehanna International Group's Palisade Bio position peaked at $1.72M in Q2 2015.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.